Last reviewed · How we verify
E coli vaccine 2 (e-coli-vaccine-2)
At a glance
| Generic name | e-coli-vaccine-2 |
|---|---|
| Sponsor | Pfizer Inc. |
| Modality | Vaccine |
| Phase | Phase 1 |
Approved indications
Common side effects
- Vaccination Site Pain (Solicited)
- Fatigue (Solicited)
- Myalgia (Solicited)
- Headache (Solicited)
- Vaccination Site Erythema (Solicited)
- Nausea (Solicited)
- Vaccination Site Swelling (Solicited)
- Diarrhoea
- Headache
- Abdominal pain
- Nausea
- Pyrexia (Solicited)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- E coli vaccine 2 CI brief — competitive landscape report
- E coli vaccine 2 updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI